Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure.
|
31512149 |
2020 |
Hypertensive disease
|
0.600 |
GeneticVariation
|
group |
BEFREE |
Current cardiovascular pharmacotherapy targets maladaptive overactivation of the renin-angiotensin-aldosterone system (RAAS), which occurs throughout the continuum of cardiovascular disease spanning from hypertension to heart failure with reduced ejection fraction.
|
31786973 |
2020 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
Across experimental models, human case reports and small intervention trials, amiloride alleviates nephrotic sodium retention and low-renin hypertension with high efficacy.
|
31789848 |
2020 |
Hypertensive disease
|
0.600 |
AlteredExpression
|
group |
BEFREE |
We performed a comparative evaluation of the diagnostic performance of the aldosterone-to-Ang II ratio and 5 renin-based diagnostic ratios, differing in methods to determine aldosterone levels and renin activity in a cohort of 110 patients with hypertension (33 patients with confirmed primary aldosteronism and 77 with essential hypertension).
|
31760886 |
2020 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
This study included 327 patients who had hypertension under plasma renin suppression and underwent captopril challenge test (CCT) between January 2007 and April 2019.CCT results were used to diagnose PA.
|
31665338 |
2020 |
Hypertensive disease
|
0.600 |
GeneticVariation
|
group |
BEFREE |
This approach may be useful for evaluating the renin-angiotensin-aldosterone system (RAAS) in pediatric patients with hypertension and RAAS dysfunction.
|
31790052 |
2020 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
This result was consistent with increased renin-independent aldosterone production and hypertension.
|
31738186 |
2020 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
One of the major components of the brain renin-angiotensin system implicated in the development of hypertension is Ang III (angiotensin III).
|
31786978 |
2020 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
Albuminuria acts as a marker of progressive chronic kidney disease and as an indicator for initiation of hypertension treatment via modulation of the renin-angiotensin-aldosterone system with angiotensin receptor blockers or angiotensin-converting enzyme inhibitors.
|
31793908 |
2020 |
Hypertensive disease
|
0.600 |
AlteredExpression
|
group |
BEFREE |
Activation of renin-angiotensin- system, nitric oxide (NO•) bioavailability and subsequent sympathoexcitation plays a pivotal role in the pathogenesis of many cardiovascular diseases, including hypertension.
|
31654775 |
2020 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
Among hypertension-related signaling mechanisms, the renin-angiotensin-aldosterone system is the leading genetic target for hypertension treatment.
|
31393243 |
2020 |
Hypertensive disease
|
0.600 |
GeneticVariation
|
group |
BEFREE |
Female rats harboring the human angiotensinogen gene [TGR(hAogen)L1623] develop a preeclamptic phenotype with hypertension and albuminuria during pregnancy when mated with male rats bearing the human renin gene [TGR(hRen)L10J] but behave physiologically normal before and after pregnancy.
|
31786987 |
2020 |
Hypertensive disease
|
0.600 |
GeneticVariation
|
group |
BEFREE |
Higher AGT levels in serum and urine in children with renal cysts may indicate the activation of the renin-angiotensin-aldosterone system, including its intrarenal part, even before the onset of hypertension.
|
31379247 |
2020 |
Hypertensive disease
|
0.600 |
GeneticVariation
|
group |
BEFREE |
Search inclusion criteria included studies describing either the incidence of HK events and any associated risk factors, or associations between HK or serum potassium concentration and adverse clinical outcomes including mortality, hospitalisation, major adverse cardiac events (MACE) and renin-angiotensin-aldosterone system inhibitors (RAASi) discontinuation in adult patients with chronic kidney disease (CKD), heart failure (HF), type 2 diabetes (T2DM) or hypertension.
|
31532067 |
2020 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
In favor of this model, genome-wide DNA methylation profiling of endothelial cells treated with TNF and different (-)-epicatechin metabolites revealed specific DNA methylation changes in gene networks controlling cell adhesion-extravasation endothelial hyperpermeability as well as gamma-aminobutyric acid, renin-angiotensin and nitric oxide hypertension pathways.
|
31756325 |
2020 |
Hypertensive disease
|
0.600 |
AlteredExpression
|
group |
BEFREE |
Low plasma renin activity was associated with the development of hypertension in the middle-aged Asian population, especially in peoples with high sodium intake.
|
29902069 |
2019 |
Hypertensive disease
|
0.600 |
GeneticVariation
|
group |
BEFREE |
Excess aldosterone leads to arterial hypertension with suppressed renin, frequently associated to hypokalemia.
|
31397984 |
2019 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
Inhibition of Renin-Angiotensin System from Conception to Young Mature Life Induces Salt-Sensitive Hypertension via Angiotensin II-Induced Sympathetic Overactivity in Adult Male Rats.
|
31468385 |
2019 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
Pharmacological inhibitors of the renin-angiotensin aldosterone system (RAAS) are used to treat hypertension.
|
31209511 |
2019 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
We compared the effects of HS plus captopril (CAP) coadministration to HS and CAP administration alone on blood pressure and renin-angiotensin-aldosterone system (RAAS) biomarkers in the rat two-kidney-one-clip (2K1C) model of hypertension.
|
31379972 |
2019 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
Hyperuricemia Inhibition Protects SD Rats Against Fructose-Induced Obesity Hypertension Via Modulation of Inflammation and Renin-Angiotensin System in Adipose Tissue.
|
31683330 |
2019 |
Hypertensive disease
|
0.600 |
AlteredExpression
|
group |
BEFREE |
These data suggest androgen-mediated activation of the renin-angiotensin system contributes to the pathogenesis of hypertension that develops in female growth-restricted offspring with aging.
|
31378101 |
2019 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
The pathophysiology of hypertension in CKD is complex and is a sequela of multiple factors, including reduced nephron mass, increased sodium retention and extracellular volume expansion, sympathetic nervous system overactivity, activation of hormones including the renin-angiotensin-aldosterone system, and endothelial dysfunction.
|
30898362 |
2019 |
Hypertensive disease
|
0.600 |
Biomarker
|
group |
BEFREE |
Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats.
|
31096810 |
2019 |
Hypertensive disease
|
0.600 |
AlteredExpression
|
group |
BEFREE |
Our research also reveals that among male workers, the levels of triglycerides, uric acid, HCY, renin activity, and the incidence of hypertension are higher than female, while high-density lipoprotein cholesterol is lower than female workers had.
|
29319008 |
2019 |